ANA ESTHER
LÓPEZ PÉREZ
Profesora asociada de Ciencias de la Salud
Universidad Rey Juan Carlos
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Rey Juan Carlos (12)
2019
-
Fluoroscopic characterization of colonic dysmotility associated to opioid and cannabinoid agonists in conscious rats
Journal of Neurogastroenterology and Motility, Vol. 25, Núm. 2, pp. 300-315
2018
-
Preclinical evaluation of the effects on the gastrointestinal tract of the antineoplastic drug vincristine repeatedly administered to rats
Neurogastroenterology and Motility, Vol. 30, Núm. 11
2017
-
Caracterización fluoroscópica en rata de la dismotilidad colónica asociada a tratamiento con morfina
Revista de la Sociedad Espanola del Dolor
-
Computer vision-based diameter maps to study fluoroscopic recordings of small intestinal motility from conscious experimental animals
Neurogastroenterology and Motility, Vol. 29, Núm. 8
-
Involvement of cannabinoid signaling in vincristine-induced gastrointestinal dysmotility in the rat
Frontiers in Pharmacology, Vol. 8, Núm. FEB
-
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
Neurogastroenterology and Motility, Vol. 29, Núm. 3
2015
-
Effects of chronic dietary exposure to monosodium glutamate on feeding behavior, adiposity, gastrointestinal motility, and cardiovascular function in healthy adult rats
Neurogastroenterology and Motility, Vol. 27, Núm. 11, pp. 1559-1570
-
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat
Neurogastroenterology and Motility, Vol. 27, Núm. 12, pp. 1721-1735
-
Valoración de actividades formativas de carácter trasversal en la Universidad Rey Juan Carlos (URJC): Seminarios sobre el cerebro
Evaluación de la Calidad de la Investigación y de la Educación Superior: libro de resúmenes XI FECIES
2014
-
X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin
Experimental Brain Research, Vol. 232, Núm. 8, pp. 2601-2612
2013
-
Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat
Neurogastroenterology and Motility, Vol. 25, Núm. 5
2012
-
The gastrointestinal pharmacology of cannabinoids: Focus on motility
Pharmacology, Vol. 90, Núm. 1-2, pp. 1-10